Post on 20-Jan-2016
Iván D Vélez MD PhD
Malaria
0,0
2,5
5,0
7,5
10,0
12,5
15,0
59 61 63 65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95 97 99 01 03
AÑO
ÍND
ICE
PA
RA
SIT
AR
IO A
NU
AL
(Ca
so
s x
10
00
ha
bit
an
tes
)
ROL OF INVESTIGATORS
Politicians, Health authorities Pharmaceutical industry
Pipeline and deliver products for Tropical diseases
multidisciplinary approach : biological, social and health sciences working together
CIDEPRO: Public-Private alliance
• No high indicators of research…. Papers, patents… but capacity … interest in scientist … •The “ spirit” of CIDEPRO: Social use of product development
•Industry: no big profit but no lost …
•Patents as indicator of success… credibility… ???? rethinking
• No high indicators of research…. Papers, patents… but capacity … interest in scientist … •The “ spirit” of CIDEPRO: Social use of product development
•Industry: no big profit but no lost …
•Patents as indicator of success… credibility… ???? rethinking
Colombian reality
Scientific committee
I+D+I Committee
Source of fundings
National department of science and technology
Universities International sponsors
S
O
O2N
S
O
S
O
OO
S
OAc
S
O
O
O
S
OH
O
O
O2N
O
O
S
O
O
O
O
NO2
O
OH
S
OH
OO
S
O
S
O
O
S
O
OO
S
O
O O
O
OAc
SO
OH
SO
OH
Help to solve problems:Thermotherapy for CL…..New, cheaper deviseLocal treatments for CL…… clinical evaluation of new compoundsArtemisa annua infusion: international collaborative project with LuxembourgMollusquicide for Fasciola hepatica controlGeneric antimalarials produced at the University drugs plants for Humaxph… cheaper
Innovation
The international standards for preclinical and clinical phases : expensive
We need develop capacity in some preclinical areas: toxicity in animal models…
PROBLEMS